Vanguard Group Inc Crispr Therapeutics Ag Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Vanguard Group Inc holds 2,298,089 shares of CRSP stock, worth $130 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,298,089

Previous 1,769,709 29.86%

Holding current value

$130 Million

Previous $60.2 Million 85.61%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$31.27 - $48.64 $16.5 Million - $25.7 Million	528,380 Added 29.86%	2,298,089 $112 Million
Q1 2025 May 09, 2025	BUY	$34.03 - $53.02 $1.15 Million - $1.79 Million	33,711 Added 1.94%	1,769,709 $60.2 Million
Q4 2024 Feb 11, 2025	BUY	$38.65 - $55.15 $408,878 - $583,431	10,579 Added 0.61%	1,735,998 $68.3 Million
Q3 2024 Nov 13, 2024	SELL	$44.62 - $62.75 $1.03 Million - $1.45 Million	-23,094 Reduced 1.32%	1,725,419 $81.1 Million
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $5.72 Million - $7.62 Million	111,714 Added 6.83%	1,748,513 $94.4 Million
Q1 2024 May 10, 2024	BUY	$60.67 - $89.12 $2.8 Million - $4.11 Million	46,148 Added 2.9%	1,636,799 $112 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $2.01 Million - $3.75 Million	51,926 Added 3.37%	1,590,651 $99.6 Million
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $346,552 - $450,465	7,635 Added 0.5%	1,538,725 $69.8 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $2.02 Million - $3.15 Million	46,521 Added 3.13%	1,531,090 $86 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $1.73 Million - $2.37 Million	42,292 Added 2.93%	1,484,569 $67.1 Million
Q4 2022 Feb 10, 2023	BUY	$39.19 - $65.67 $269,117 - $450,955	6,867 Added 0.48%	1,442,277 $58.6 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $6.86 Million - $9.41 Million	112,269 Added 8.49%	1,435,410 $93.8 Million
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $4.58 Million - $7.82 Million	105,852 Added 8.7%	1,323,141 $80.4 Million
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $46.8 Million - $69.8 Million	880,463 Added 261.4%	1,217,289 $76.4 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $1.66 Million - $2.64 Million	-23,715 Reduced 6.58%	336,826 $25.5 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $10.7 Million - $15.2 Million	96,783 Added 36.69%	360,541 $40.4 Million
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $26.6 Million - $42.7 Million	263,758 New	263,758 $42.7 Million

Others Institutions Holding CRSP

# of Institutions

529

Shares Held

68.7M

Call Options Held

3.79M

Put Options Held

2.29M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.42B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Crispr Therapeutics Ag Transaction History